CORC

在结果中检索

CORC

浏览/检索结果: 共138条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
The Application of 20 inch MCP-PMT In LHAASO-WCDA 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  You, Xiaohao;  Gao, Bo;  Chen, MingJun;  Li, HuiCai;  Liu, Cheng
收藏  |  浏览/下载：21/0  |  提交时间：2023/01/16
Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China 会议论文
作者:  Liu, Jiangtao;  Zhou, Ji;  Yao, Jinxi;  Zhang, Xiuxia;  Li, Lanyu
收藏  |  浏览/下载：23/0  |  提交时间：2020/12/18
Simulation study on liquid-end of high-pressure and large-flow-rate reciprocating pump 会议论文
Wuhan, China, April 10, 2019 - April 13, 2019
作者:  Ran, Li;  Wei, Wenshu;  Hao, Liu;  Yi, Zhu;  Hong, Ji
收藏  |  浏览/下载：1/0  |  提交时间：2020/11/15
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
A comparative study of PD-L1 immunohistochemistry assays for primary liver cancer 会议论文
作者:  Du, Min;  Zhang, Wujian;  Cai, Yumeng;  Wei, Bo;  Si, Zhuyue
收藏  |  浏览/下载：20/0  |  提交时间：2019/12/05
A comparative study of PD-L1 immunohistochemistry assays for primary liver cancer 会议论文
作者:  Du, Min;  Zhang, Wujian;  Cai, Yumeng;  Wei, Bo;  Si, Zhuyue
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Prognosis assessment of acute-on-chronic liver failure in patients with hepatitis B virus-related cirrhosis requires specific criteria 会议论文
作者:  Gu Wenyi;  Deng, Guohong;  Zheng, Xin;  Chen, Jinjun;  Wang, Xian-bo
收藏  |  浏览/下载：90/0  |  提交时间：2019/12/05
The sixth visual object tracking VOT2018 challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Kristan, Matej;  Leonardis, Ale;  Matas, Jií;  Felsberg, Michael;  Pflugfelder, Roman
收藏  |  浏览/下载：142/0  |  提交时间：2019/12/02
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace